Compare SNPS & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNPS | CI |
|---|---|---|
| Founded | 1986 | 1792 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0B | 76.9B |
| IPO Year | 1992 | N/A |
| Metric | SNPS | CI |
|---|---|---|
| Price | $468.51 | $271.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 17 |
| Target Price | ★ $566.13 | $358.29 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 12-10-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.20% |
| EPS Growth | N/A | ★ 114.09 |
| EPS | 8.05 | ★ 22.63 |
| Revenue | $7,054,178,000.00 | ★ $268,077,000,000.00 |
| Revenue This Year | $39.78 | $12.88 |
| Revenue Next Year | $10.81 | $4.55 |
| P/E Ratio | $56.94 | ★ $12.11 |
| Revenue Growth | 15.12 | ★ 15.26 |
| 52 Week Low | $365.74 | $239.51 |
| 52 Week High | $651.73 | $350.00 |
| Indicator | SNPS | CI |
|---|---|---|
| Relative Strength Index (RSI) | 59.34 | 49.38 |
| Support Level | $452.50 | $270.62 |
| Resistance Level | $482.23 | $278.00 |
| Average True Range (ATR) | 14.77 | 5.27 |
| MACD | 1.10 | 1.00 |
| Stochastic Oscillator | 60.09 | 73.59 |
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.